Article
Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jul 2012
Hofman P, Ilie M, Hofman V, Roux S, Valent A, Bernheim A, Alifano M, Leroy-Ladurie F, Vaylet F, Rouquette I, Validire P, Beau-Faller M, Lacroix L, Soria J C, Fouret P
Abstract excerpt
BACKGROUND: Immunohistochemistry has been proposed as a specific and sensitive method to identify EGFR mutations or ALK rearrangements in lung tumours. PATIENTS AND METHODS: We assessed EGFR and KRAS by direct sequencing in 154 patients with lung adenocarcinoma. ALK rearrangements were assayed by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
